# Alert on Respreeza medication (alpha-1-antitrypsin)

> Security information intended for hospital pharmacists signals a risk of inability to administer and infection linked to damage to the integrity of the Respreeza vial.

**In brief**: Health event (severity: low) nationwide, first detected on 9 November 2026 at 00:00. Reported by 1 source (1 article), last updated on 9 November 2026 at 00:00.

- Category: Health
- Severity: Low
- Place: Nationwide
- First detected: 9 November 2026 at 00:00
- Updated: 9 November 2026 at 00:00
- Web page: https://acturadar.com/en/events/13901-alert-on-respreeza-medication-alpha-1-antitrypsin

## Sources (1 articles)

- [Respreeza (alpha-1-antitrypsine humaine) : risque d’impossibilité d’administration et d’infection potentielle en raison d’une altération de l’intégrité du flacon](https://ansm.sante.fr/informations-de-securite/respreeza-alpha-1-antitrypsine-humaine-risque-dimpossibilite-dadministration-et-dinfection-potentielle-en-raison-dune-alteration-de-lintegrite-du-flacon) — ANSM, 9 November 2026 at 00:00

---

Cite as: Acturadar, “Alert on Respreeza medication (alpha-1-antitrypsin)”, https://acturadar.com/en/events/13901-alert-on-respreeza-medication-alpha-1-antitrypsin
Methodology: https://acturadar.com/en/methodology